Alpha Cognition (ACOG) Expected to Announce Earnings on Thursday

Alpha Cognition (NASDAQ:ACOGGet Free Report) is projected to release its Q3 2025 results after the market closes on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.46) per share and revenue of $3.2070 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 13, 2025 at 4:30 PM ET.

Alpha Cognition (NASDAQ:ACOGGet Free Report) last announced its earnings results on Thursday, August 14th. The company reported ($0.65) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.19). The company had revenue of $1.66 million for the quarter, compared to analyst estimates of $2.32 million.

Alpha Cognition Price Performance

ACOG stock opened at $6.26 on Tuesday. Alpha Cognition has a one year low of $3.75 and a one year high of $11.54. The stock has a market cap of $130.85 million, a PE ratio of -3.91 and a beta of 2.62. The firm has a 50 day simple moving average of $7.48 and a two-hundred day simple moving average of $8.41.

Insiders Place Their Bets

In related news, Director Phillip Joseph Mertz sold 27,778 shares of Alpha Cognition stock in a transaction on Monday, August 18th. The shares were sold at an average price of $9.00, for a total value of $250,002.00. Following the transaction, the director owned 22,462 shares in the company, valued at $202,158. This trade represents a 55.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert James Wills purchased 15,000 shares of the stock in a transaction on Monday, August 18th. The stock was acquired at an average cost of $8.49 per share, with a total value of $127,350.00. Following the completion of the purchase, the director directly owned 15,000 shares of the company’s stock, valued at $127,350. The trade was a ? increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 14.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Alpha Cognition

Hedge funds and other institutional investors have recently modified their holdings of the stock. Cable Car Capital LP grew its position in Alpha Cognition by 68.8% during the 2nd quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock worth $8,108,000 after acquiring an additional 354,278 shares during the last quarter. Manatuck Hill Partners LLC boosted its stake in shares of Alpha Cognition by 74.6% during the second quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company’s stock valued at $1,092,000 after purchasing an additional 50,000 shares during the period. Marshall Wace LLP bought a new position in shares of Alpha Cognition in the second quarter worth approximately $600,000. Massar Capital Management LP bought a new position in shares of Alpha Cognition in the second quarter worth approximately $116,000. Finally, Geode Capital Management LLC purchased a new position in shares of Alpha Cognition in the second quarter worth $112,000.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ACOG. Wall Street Zen downgraded shares of Alpha Cognition from a “hold” rating to a “sell” rating in a report on Saturday, October 18th. HC Wainwright lowered their price target on Alpha Cognition from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Monday, October 20th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $18.00.

View Our Latest Stock Analysis on ACOG

Alpha Cognition Company Profile

(Get Free Report)

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Featured Stories

Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.